IIFT MBA 2021: Indian Institute of Foreign Trade begins registration at iift.nta.nic.in, apply by 20 Dec

-

IIFT MBA 2021: The online application window for the Indian Institute of Foreign Trade (IIFT) MBA programme has been opened at iift.nta.nic.in. NTA, which is the IIFT 2021 MBA administering body, will allow candidates to register online for the MBA IIFT 2021-23 academic programme till 20 December.

According to reports, the IIFT MBA application process includes registration, filling the online IIFT MBA application form, uploading of scanned documents and paying the IIFT MBA examination fee.

The exam authority has so far not given the date for release of admit cards for the entrance exam. The exam, however, is scheduled to be held on 24 January, reports said.

Here's how to register for IIFT MBA 2021:

Candidates need to first visit the official website iift.nta.nic.in and click on the IIFT application form 2021. Following the submission of basic details, they have to create IIFT MBA login IDs and re-login with the system-generated ID.

After filling in personal and academic details and uploading documents in specified formats, they need to submit the IIFT application form and make the online IIFT registration payment to complete the process.

At the time of registration, General/OBC category candidates need to pay a fees of Rs 2,500, while SC/ST/ PH category students need to play a fee of Rs 1,000.

The IIFT is a national-level entrance examination conducted for admission to the postgraduate management programmes offered by institutions. The exam is conducted for 2 hours in the online mode and reservation for the exam is done as per government regulations.

The eligibility criteria for applying to the MBA programme include a recognised Bachelor’s degree of minimum 3 years’ duration in any discipline with 50 percent marks in Graduation (45% for SC/ST/PWD candidates). Candidates who are appearing in the final year examination of Graduation can also apply for the programme and it has no age-limit.



from Firstpost India Latest News https://ift.tt/2IhilIU
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more